Article Menu
-
Academic Editor
Christian Klein
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Root, A. R.
- Cao, W.
- Li, B.
- LaPan, P.
- Meade, C.
- Sanford, J.
- Jin, M.
- O’Sullivan, C.
- Cummins, E.
- Lambert, M.
- Sheehan, A. D.
- Ma, W.
- Gatto, S.
- Kerns, K.
- Lam, K.
- D’Antona, A. M.
- Zhu, L.
- Brady, W. A.
- Benard, S.
- King, A.
- He, T.
- Racie, L.
- Arai, M.
- Barrett, D.
- Stochaj, W.
- LaVallie, E. R.
- Apgar, J. R.
- Svenson, K.
- Mosyak, L.
- Yang, Y.
- Chichili, G. R.
- Liu, L.
- Li, H.
- Burke, S.
- Johnson, S.
- Alderson, R.
- Finlay, W. J. J.
- Lin, L.
- Olland, S.
- Somers, W.
- Bonvini, E.
- Gerber, H.
- May, C.
- Moore, P. A.
- Tchistiakova, L.
- Bloom, L.
- on Google Scholar
- Root, A. R.
- Cao, W.
- Li, B.
- LaPan, P.
- Meade, C.
- Sanford, J.
- Jin, M.
- O’Sullivan, C.
- Cummins, E.
- Lambert, M.
- Sheehan, A. D.
- Ma, W.
- Gatto, S.
- Kerns, K.
- Lam, K.
- D’Antona, A. M.
- Zhu, L.
- Brady, W. A.
- Benard, S.
- King, A.
- He, T.
- Racie, L.
- Arai, M.
- Barrett, D.
- Stochaj, W.
- LaVallie, E. R.
- Apgar, J. R.
- Svenson, K.
- Mosyak, L.
- Yang, Y.
- Chichili, G. R.
- Liu, L.
- Li, H.
- Burke, S.
- Johnson, S.
- Alderson, R.
- Finlay, W. J. J.
- Lin, L.
- Olland, S.
- Somers, W.
- Bonvini, E.
- Gerber, H.
- May, C.
- Moore, P. A.
- Tchistiakova, L.
- Bloom, L.
- on PubMed
- Root, A. R.
- Cao, W.
- Li, B.
- LaPan, P.
- Meade, C.
- Sanford, J.
- Jin, M.
- O’Sullivan, C.
- Cummins, E.
- Lambert, M.
- Sheehan, A. D.
- Ma, W.
- Gatto, S.
- Kerns, K.
- Lam, K.
- D’Antona, A. M.
- Zhu, L.
- Brady, W. A.
- Benard, S.
- King, A.
- He, T.
- Racie, L.
- Arai, M.
- Barrett, D.
- Stochaj, W.
- LaVallie, E. R.
- Apgar, J. R.
- Svenson, K.
- Mosyak, L.
- Yang, Y.
- Chichili, G. R.
- Liu, L.
- Li, H.
- Burke, S.
- Johnson, S.
- Alderson, R.
- Finlay, W. J. J.
- Lin, L.
- Olland, S.
- Somers, W.
- Bonvini, E.
- Gerber, H.
- May, C.
- Moore, P. A.
- Tchistiakova, L.
- Bloom, L.
Need Help?
Order Article Reprints
Journal: Antibodies, 2016
Volume: 5
Number: 6
6
Article:
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
Authors:
by
Adam R. Root, Wei Cao, Bilian Li, Peter LaPan, Caryl Meade, Jocelyn Sanford, Macy Jin, Cliona O’Sullivan, Emma Cummins, Matthew Lambert, Alfredo D. Sheehan, Weijun Ma, Scott Gatto, Kelvin Kerns, Khetemenee Lam, Aaron M. D’Antona, Lily Zhu, William A. Brady, Susan Benard, Amy King, Tao He, Lisa Racie, Maya Arai, Dianah Barrett, Wayne Stochaj, Edward R. LaVallie, James R. Apgar, Kristine Svenson, Lidia Mosyak, Yinhua Yang, Gurunadh R. Chichili, Liqin Liu, Hua Li, Steve Burke, Syd Johnson, Ralph Alderson, William J. J. Finlay, Laura Lin, Stéphane Olland, William Somers, Ezio Bonvini, Hans-Peter Gerber, Chad May, Paul A. Moore, Lioudmila Tchistiakova and Laird Bloomadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2073-4468/5/1/6
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Root, A.R.; Cao, W.; Li, B.; LaPan, P.; Meade, C.; Sanford, J.; Jin, M.; O’Sullivan, C.; Cummins, E.; Lambert, M.; et al. Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. Antibodies 2016, 5, 6. https://doi.org/10.3390/antib5010006
Root AR, Cao W, Li B, LaPan P, Meade C, Sanford J, Jin M, O’Sullivan C, Cummins E, Lambert M, et al. Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. Antibodies. 2016; 5(1):6. https://doi.org/10.3390/antib5010006
Chicago/Turabian StyleRoot, Adam R., Wei Cao, Bilian Li, Peter LaPan, Caryl Meade, Jocelyn Sanford, Macy Jin, Cliona O’Sullivan, Emma Cummins, Matthew Lambert, and et al. 2016. "Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer" Antibodies 5, no. 1: 6. https://doi.org/10.3390/antib5010006
APA StyleRoot, A. R., Cao, W., Li, B., LaPan, P., Meade, C., Sanford, J., Jin, M., O’Sullivan, C., Cummins, E., Lambert, M., Sheehan, A. D., Ma, W., Gatto, S., Kerns, K., Lam, K., D’Antona, A. M., Zhu, L., Brady, W. A., Benard, S., ... Bloom, L. (2016). Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. Antibodies, 5(1), 6. https://doi.org/10.3390/antib5010006
